Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 97, Issue 1, Pages 16-18Publisher
WILEY-BLACKWELL
DOI: 10.1002/cpt.9
Keywords
-
Categories
Ask authors/readers for more resources
The development of novel therapeutics depends and builds upon the validity and reproducibility of previously published data and findings. Yet irreproducibility is pervasive in preclinical life science research and can be traced to cumulative errors or flaws in several areas, including reference materials, study design, laboratory protocols, and data collection and analysis. The expanded development and use of consensus-based standards and well-documented best practices is needed to both enhance reproducibility and drive therapeutic innovations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available